Berrino, Enrico
Filippi, Roberto
Visintin, Clara
Peirone, Serena http://orcid.org/0000-0002-5195-7908
Fenocchio, Elisabetta
Farinea, Giovanni
Veglio, Franco
Aglietta, Massimo
Sapino, Anna
Cereda, Matteo http://orcid.org/0000-0003-1799-5537
Visintin, Rosella
Pasini, Barbara http://orcid.org/0000-0002-4373-1212
Marchiò, Caterina http://orcid.org/0000-0003-2024-6131
Funding for this research was provided by:
Ministero dell'Istruzione, dell'Università e della Ricerca (FPRC 5xmille 2015 MIUR)
Associazione Italiana per la Ricerca sul Cancro (MFAG20566)
Ministero della Salute (Ricerca corrente, 5X1000)
Article History
Received: 4 April 2021
Accepted: 11 February 2022
First Online: 8 March 2022
Competing interests
: C.M. has received personal consultancy fees from Bayer, Roche, AstraZeneca, Daiichi Sankyo, outside the scope of the present study. The authors declare no competing interests.